ultimate nuclear stack? need more suggestions bruhh
    Technology 8/12/2025

    At a glance
    In this hair loss treatment regimen post, the primary subjects mentioned are
    💊 Dutasteride (oral)
    💧 Dutasteride (topical)
    💧 GT20029 (topical)
    💧 RU58841 (topical)
    💧 Pyrilutamide (topical)
    Minoxidil (foam)
    💊 Minoxidil (oral)
    Microneedling weekly
    💧 Ketoconazole shampoo (topical)
    the tone is humorous.

    Other terms

    The conversation discusses an extensive hair loss treatment regimen including dutasteride, GT20029, RU58841, pyrilutamide, minoxidil, microneedling, ketoconazole shampoo, and experimental compounds. The user humorously describes their approach as a comprehensive strategy to combat hair loss while maintaining hair growth.
    View this post in the Community →

    Similar Community Posts Join

    5 / 1000+ results

      community It’s over. NOTHING has worked.

      in Chat  95 upvotes 3 years ago
      A user who has been trying various treatments for hair loss for four years, with no success. Suggestions include use of minoxidil, finasteride, RU58841, microneedling, supplements and multivitamins, lifestyle changes, scalp biopsy, and SMP.

      community Ultimate Stack without nuking your gender (you'll go broke)

      in Treatment  81 upvotes 1 year ago
      A hair loss treatment plan includes finasteride, dutasteride, RU58841, pyrilutamide, minoxidil, and microneedling to inhibit DHT and promote hair growth. It also recommends supplements like Reishi and Lion’s Mane mushrooms, and a shampoo with ketoconazole, caffeine, and melatonin.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  443 upvotes 3 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Kintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World’s First Topical Use PROTAC Compound

      in Research/Science  128 upvotes 3 years ago
      The conversation discusses positive initial trial results for GT20029, a topical compound for hair loss that degrades androgen receptors, potentially requiring only weekly application. Participants express hope for this treatment to be more effective and convenient than current options like Minoxidil, Finasteride, and RU58841.

    Related Research

    6 / 1000+ results